Cancer Immunology, Immunotherapy is providing a timely and open access publication of original discovery and developments in basic and translational research ...
癌症免疫学和免疫疗法 (Cancer Immunology and Immunotherapy) 专题是Cancers期刊15个专题之一,由Dr. Barbara Wegiel担任主编,Dr. Subbaya Subramanian担任副主编,共有130位全球知名学者担任该专题编委。截止2021年12月,该专题共开设了48个特刊。 01 专题主编介绍 主编 Dr. Barbara Wegiel 美国哈佛医学院 Dr. Barbara ...
根据官网的数据,Cancer Immunology, Immunotherapy第一次决定的时间是7天。 5. 版面费 Cancer Immunology, Immunotherapy是一本接受开放获取期刊。根据官网显示发表文章需要版面费£2790.00/$4390.00/€3390.00。 6.期刊接受类型 期刊接受的稿件类型包括原创研究、综述文章、临床病例研究、临床试验、观点、评述、书评。 研究...
《癌症免疫学免疫治疗》(Cancer Immunology Immunotherapy)是一本以医学-免疫学综合研究为特色的国际期刊。该刊由Springer Berlin Heidelberg出版商创刊于1976年,刊期Monthly。该刊已被国际重要权威数据库SCIE收录。期刊聚焦医学-免疫学领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域同行进行快速...
Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology Keystone Symposia Meeting Summary The Keystone Symposia conference on Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology was held at the Fairmont Chateau in Whistler, British Columbia, Canada, on March 19-...
Cancer immunotherapy aims to promote the activity of cytotoxic T lymphocytes (CTLs) within a tumour, assist the priming of tumour-specific CTLs in lymphoid organs and establish efficient and durable antitumour immunity. During priming, help signals are relayed from CD4+ T cells to CD8+ T cells...
cancerimmunotherapyimmunologyimmuneipilimumabprovenge CurrentTopicsinMicrobiologyandImmunology344 CancerImmunologyandImmunotherapy Bearbeitetvon GlennDranoff 1.Auflage2011.Buch.xiv,306S.Hardcover ISBN9783642141355 Format(BxL):15,5x23,5cm Gewicht:643g WeitereFachgebiete>Medizin>KlinischeundInnereMedizin>Onkologie, Psych...
Cancer Immunology Immunotherapy创刊于1976年,由Springer Berlin Heidelberg出版商出版,收稿方向涵盖医学 - 免疫学全领域,此刊是该细分领域中属于非常不错的SCI期刊,在行业细分领域中学术影响力较大,专业度认可很高,所以对原创文章要求创新性较高,如果您的文章质量很高,可以尝试。平均审稿速度 约1月 ,影响因子指数4.6,...
Volume 1: Delivery Strategies and Engineering Technologies in Cancer Immunotherapycreates a comprehensive treaty that engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery...
2021年8月5日,上海中医药大学博鳌国际医院国际再生医学研究中心(以下简称博鳌国际医院国际再生医学研究中心)在国际权威SCI杂志《Frontiers in Immunology》上发表了综述性论文——《Inflammasome Signaling: ANovel Paradigm of Hub Platform in Innate Immunity for Cancer Immunology and Immunotherapy》,中文标题为《为炎性...